These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36313750)

  • 1. Analysis of factors influencing the clinical outcome after surgery and
    Li Y; Rao M; Zheng C; Huang J; Fang D; Xiong Y; Yuan G
    Front Endocrinol (Lausanne); 2022; 13():1015798. PubMed ID: 36313750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY.
    Liu YQ; Li H; Liu JR; Lin YS
    Endocr Pract; 2019 Dec; 25(12):1286-1294. PubMed ID: 31412228
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinicopathological features affecting the efficacy in
    Xu X; Li C; Yu X; Wang G; Guo Y; Ni H; Zhao W; Wang Y; Dong B
    Front Endocrinol (Lausanne); 2024; 15():1382009. PubMed ID: 39086895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIZE OF THE LARGEST METASTATIC FOCUS TO THE LYMPH NODE IS ASSOCIATED WITH INCOMPLETE RESPONSE OF PN1 PAPILLARY THYROID CARCINOMA.
    Deng Y; Zhu G; Ouyang W; Pan L; Feng H; Wu J; Chen P; Wang J; Xian J
    Endocr Pract; 2019 Sep; 25(9):887-898. PubMed ID: 31170371
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of Curative Effect and Influencing Factors of N1 Stage Papillary Thyroid Micro-Carcinoma and Papillary Thyroid Non-Micro Carcinoma After Initial Radioactive Iodine Ablation Therapy.
    Yun C; Wu M; Xiao J; Liu Y; Zhang W; Cao J
    Cancer Manag Res; 2021; 13():1427-1434. PubMed ID: 33613032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PROGNOSTIC VALUE OF LYMPH NODE UPTAKE ON PRETREATMENT F-18 FDG PET/CT IN PATIENTS WITH N1B PAPILLARY THYROID CARCINOMA.
    Lee CH; Lee SW; Son SH; Hong CM; Jeong JH; Jeong SY; Ahn BC; Lee J
    Endocr Pract; 2019 Aug; 25(8):787-793. PubMed ID: 31013158
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact factors for the outcome of the first
    Shangguan L; Fang S; Zhang P; Han S; Shen X; Geng Y; Luo D; Zhao C
    Ann Nucl Med; 2019 Mar; 33(3):177-183. PubMed ID: 30515649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the ratio superior to the number of metastatic lymph nodes in addressing the response in patients with papillary thyroid cancer?
    Gao W; Zhao T; Liang J; Lin Y
    Medicine (Baltimore); 2018 Jan; 97(3):e9664. PubMed ID: 29505008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.
    Chang Q; Zhang J; Wang Y; Li H; Du X; Zuo D; Yin D
    Front Endocrinol (Lausanne); 2022; 13():937049. PubMed ID: 35909521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and prognosis value of the number of metastatic lymph nodes in patients with papillary thyroid carcinoma.
    Zhan L; Feng HF; Yu XZ; Li LR; Song JL; Tu Y; Yuan JP; Chen C; Sun SR
    BMC Surg; 2022 Jun; 22(1):235. PubMed ID: 35725426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prediction and investigation of the potential risk factors for the upper mediastinal metastasis of papillary thyroid carcinoma].
    Liu Y; Xu SY; Liu K; Wang XL; Liu SY; Xu ZG; Liu J
    Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):477-483. PubMed ID: 33902211
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-Term Efficacy of Lymph Node Reoperation for Persistent Papillary Thyroid Cancer: 13-Year Follow-Up.
    Onuma AE; Beal EW; Nabhan F; Hughes T; Farrar WB; Phay J; Ringel MD; Kloos RT; Shirley LA
    Ann Surg Oncol; 2019 Jun; 26(6):1737-1743. PubMed ID: 30820785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy.
    Xing Z; Qiu Y; Li Z; Zhang L; Fei Y; Zhu J; Su A
    BMC Surg; 2021 Jan; 21(1):53. PubMed ID: 33482804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Factors for Excellent Response to Initial Therapy in Patients With Papillary Thyroid Cancer From a Prospective Multicenter Study.
    Dong WW; Zhang DL; He L; Shao L; Wang ZH; Lv CZ; Zhang P; Huang T; Zhang H
    Front Oncol; 2022; 12():840714. PubMed ID: 35860552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history, predictive factors of apparent disease (structural or biochemical) and spontaneous excellent response in patients with papillary thyroid carcinoma and indeterminate response to initial therapy with radioiodine.
    Rosario PW; Mourão GF
    Endocrine; 2022 Jun; 76(3):671-676. PubMed ID: 35347578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node fine-needle aspiration washout thyroglobulin in papillary thyroid cancer: Diagnostic value and the effect of thyroglobulin antibodies.
    Konca Degertekin C; Yalcin MM; Cerit T; Ozkan C; Kalan I; Iyidir OT; Altinova AE; Akturk M; Toruner F; Akin M; Cakir N
    Endocr Res; 2016 Nov; 41(4):281-289. PubMed ID: 26905960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of skip lateral lymph node metastasis in papillary thyroid carcinoma.
    Hou J; Zhang Y; Fan Y; Wu B
    Eur Arch Otorhinolaryngol; 2021 Feb; 278(2):493-498. PubMed ID: 32607832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study.
    Li X; Zhang H; Zhou Y; Cheng R
    World J Surg Oncol; 2021 Apr; 19(1):138. PubMed ID: 33941214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Serum Thyroglobulin Levels Predict Radioiodine Therapy Outcome in Papillary Thyroid Microcarcinoma Patients.
    Cheng X; Fan Y; Ye W; Xu S; Wu J; Gao W; Bao J; Yu H; Zhang L
    Horm Metab Res; 2024 Jul; 56(7):498-503. PubMed ID: 38503312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroglobulin Measurement Through Fine-Needle Aspiration for Optimizing Neck Node Dissection in Papillary Thyroid Cancer.
    Jia X; Wang Y; Liu Y; Wang X; Yao X; Tao R; Liu H; Yang A; Gao R
    Ann Surg Oncol; 2022 Jan; 29(1):88-96. PubMed ID: 34386915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.